4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-20-034537
Director sold 15,000 shares at an average $148.95 ($2,234,266)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2020-12-16 | Sale | −914 | $147.00 | $134,360 | 6,734 | D |
| Bolzon Bradley J PhD Director | 2020-12-16 | Sale | −878 | $147.00 | $129,068 | 346,308 | I |
| Bolzon Bradley J PhD Director | 2020-12-16 | Sale | −2,679 | $148.28 | $397,245 | 4,055 | D |
| Bolzon Bradley J PhD Director | 2020-12-16 | Sale | −2,576 | $148.28 | $381,972 | 343,732 | I |
| Bolzon Bradley J PhD Director | 2020-12-16 | Sale | −2,091 | $149.12 | $311,815 | 1,964 | D |
| Bolzon Bradley J PhD Director | 2020-12-16 | Sale | −2,009 | $149.12 | $299,586 | 341,723 | I |
| Bolzon Bradley J PhD Director | 2020-12-16 | Sale | −995 | $150.14 | $149,392 | 969 | D |
| Bolzon Bradley J PhD Director | 2020-12-16 | Sale | −958 | $150.14 | $143,837 | 340,765 | I |
| Bolzon Bradley J PhD Director | 2020-12-16 | Sale | −969 | $151.05 | $146,365 | 0 | D |
| Bolzon Bradley J PhD Director | 2020-12-16 | Sale | −931 | $151.05 | $140,625 | 339,834 | I |
| Open-market sales · 15,000 sh · avg $148.95 · $2,234,266 | |||||||
Loading xslF345X03/doc4.xml…